LifeScience Vaccines
Indian Immunologicals Ltd (IIL), led by its Chairman Dr. Meenesh Shah and Managing Director Dr. K. Anand Kumar, has generously donated 10,000 doses of its ...
July 17, 2024 | News
Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-...
July 16, 2024 | News
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Contributes to expand...
July 05, 2024 | News
PharmaJet®, a company dedicated to enhancing the performance and outcomes of injectables through innovative delivery systems, today announced that thei...
June 28, 2024 | News
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Re...
June 28, 2024 | News
Multiple Phase III studies are expected to be conducted across North America, Central and South America, UK and other global clinical sites VaxTrials, p...
June 25, 2024 | News
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development program conti...
June 10, 2024 | News
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...
June 03, 2024 | News
- With this investment, SII will acquire 20% stake in IntegriMedical -  ...
May 20, 2024 | News
Timely access to vaccines is crucial for public health, especially in regions with diverse regulatory landscapes like the Asia Pacific. Bio...
May 17, 2024 | Interview
The Health Sciences Authority (HSA) of Singapore has approved Arexvy (recombinant, AS01E adjuvanted) for active immunisation to prevent lower respiratory t...
May 16, 2024 | News
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...
May 13, 2024 | News
The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease through two seasons has been approved by Hong K...
May 09, 2024 | News
The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...
May 09, 2024 | News
Most Read
Bio Jobs
News
Editor Picks